Director Frank Slootman of Snowflake Inc. filed a Form 4 on November 20, 2026, reporting the exercise of stock options and the sale of common stock on November 18 and 19, 2026, pursuant to a Rule 10b5-1 trading plan.
Key Highlights
- Option exercises: Slootman exercised stock options covering a total of 300,000 shares (225,353 on November 18 and 74,647 on November 19) at an exercise price of $8.88 per share.
- Shares sold on November 18: 224,353 shares of common stock were disposed of across multiple price tranches, with weighted-average sale prices ranging from $269.807 to $280.075.
- Shares sold on November 19: 74,647 shares of common stock were disposed of across multiple price tranches, with weighted-average sale prices ranging from $288.67 to $296.303.
- Remaining direct ownership: Following all reported transactions, Slootman directly held 19,024 shares of common stock, plus an additional amount that includes shares to be issued in connection with the vesting of one or more restricted stock units, according to the filing.
- Indirect holdings: The filing also reports indirect beneficial ownership of shares held through five trusts, totaling 2,174; 16,300; 78,893; 56,331; and 56,331 shares respectively.
- 10b5-1 plan: The filing states all exercises and sales were effected pursuant to a 10b5-1 trading plan adopted by Slootman on September 19, 2025.
- Remaining options: After the two exercises, Slootman's directly held stock options (right to buy at $8.88, expiring 05/28/2029) totaled 3,536,655 shares, according to the filing.
Slootman's November 2026 Option Exercises and Share Sales at Snowflake
According to the Form 4 filed with the SEC on November 20, 2026, Frank Slootman, who is listed as a director of Snowflake Inc. (NYSE:SNOW), reported two stock option exercises and a series of open-market share sales on November 18 and 19, 2026. The filing states that all transactions were made pursuant to a Rule 10b5-1 trading plan that Slootman adopted on September 19, 2025. The options exercised on both days carried an exercise price of $8.88 per share and are described in the filing as fully vested.
On November 18, Slootman exercised options covering 225,353 shares and subsequently sold shares across eleven price tranches with weighted-average prices from $269.807 to $280.075. The individual sale amounts in those tranches ranged from 343 shares to 78,613 shares. On November 19, he exercised options covering 74,647 shares and sold shares across nine price tranches at weighted-average prices from $288.67 to $296.303. The filing notes that all weighted-average prices represent sales executed across multiple sub-transactions within each price range, and Slootman undertakes to provide full per-price detail upon request.
After all reported transactions, the filing shows Slootman's direct beneficial ownership stood at 19,024 shares of common stock. The filing notes that this figure includes shares to be issued in connection with the vesting of one or more restricted stock units. In addition, Slootman indirectly holds shares through five separately named trusts: the Slootman Living Trust dated 9/8/1999 (2,174 shares), the Slootman Grandchildren's Trust dated 7/28/2022 (16,300 shares), the Slootman 2023 Children's Trust dated 9/25/2023 (78,893 shares), the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 (56,331 shares), and the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 (56,331 shares), according to the filing.
What Was Disclosed
The filing disclosed director Frank Slootman's exercise of 300,000 fully vested stock options at $8.88 per share and the subsequent sale of those shares on November 18-19, 2026, all under a pre-established 10b5-1 trading plan adopted September 19, 2025, leaving 19,024 shares held directly.




Please wait processing your request...